not used title

not used title

A new large-scale survey of 20,000 Americans covering all states and Congressional districts shows a majority find health care coverage costs unreasonable and a top priority health care issue for policymakers to address today. At the same time, the survey conducted with Morning Consult also shows Americans reject so-called government “negotiation” once they learn it could restrict access and choice and chill the innovation of new treatments and cures.

Here is what you should know from the new survey, representative of all 50 states, the District of Columbia and all Congressional districts:

Over 6 in 10 Americans reject price setting policies such as government “negotiation” once they learn it could sacrifice access, innovation and choice. A majority of Americans in every state and the District of Columbia oppose government “negotiation” as a way to address health care costs if it could:

• Take away power from doctors to prescribe the medicines that best meet the needs of their patients, and instead put the government in charge of those decisions – on average 66% oppose.
• Limit people’s access to newer prescription drugs – on average 64% oppose; and
• Reduce access to medicines for seniors and people with disabilities – on average 62% oppose.

*full state-by-state breakdown of results below
Click here for a breakdown of results by Congressional districts

Americans’ top issue priorities are the economy and COVID-19 recovery. When shifting focus to health care, however, coverage-related costs, specifically, out-of-pocket costs not covered by insurance and insurance premiums is the top concern.

• Americans in all 50 states and the District of Columbia noted their top two priorities overall are the economy and COVID-19 pandemic recovery, with few exceptions.
• The bottom priorities noted are education, taxes and prescription drug prices, of the 11 priorities listed: No state or district listed prescription drug prices above 3% or above 10th on the list of 11 policy priorities.
• When it comes to health care, Americans in all 50 states and the District of Columbia are most concerned with out-of-pocket costs not covered by insurance (30% of respondents on average) and the cost of health insurance premiums (29%).
• When asked to prioritize health care costs, approximately two-thirds of Americans (64%) believe Congress should focus on reducing the cost of health care coverage (23% of Americans want them to focus on prescription drug costs, and 13% don’t know enough to say).
• Two-thirds (66%) of Americans from all 50 states and the District of Columbia find their out-of-pocket health care costs “unreasonable.”

The data show Americans want Congress to put emphasis on patient-centered solutions that address the real health care issues they face, like rising out-of-pocket costs and health insurance premiums, while preserving access, innovation and choice. Learn how at PhRMA.org/BetterWay.

Please click here for full survey memo, topline and methodology.

+++

* % oppose negotiation with information

 

It could limit people’s access to newer prescription medicines
State	Total Oppose Negotiation
Alabama	66%
Alaska	56%
Arizona	62%
Arkansas	67%
California	58%
Colorado	61%
Connecticut	62%
Delaware	66%
District of Columbia	53%
Florida	66%
Georgia	63%
Hawaii	62%
Idaho	67%
Illinois	63%
Indiana	67%
Iowa	68%
Kansas	66%
Kentucky	67%
Louisiana	65%
Maine	66%
Maryland	62%
Massachusetts	62%
Michigan	64%
Minnesota	65%
Mississippi	66%
Missouri	67%
Montana	66%
Nebraska	66%
Nevada	63%
New Hampshire	64%
New Jersey	61%
New Mexico	62%
New York	61%
North Carolina	64%
North Dakota	65%
Ohio	66%
Oklahoma	64%
Oregon	64%
Pennsylvania	64%
Rhode Island	63%
South Carolina	67%
South Dakota	66%
Tennessee	67%
Texas	61%
Utah	64%
Vermont	65%
Virginia	62%
Washington	60%
West Virginia	67%
Wisconsin	65%
Wyoming	63%

 

Cynthia Hicks

Cynthia Hicks is Senior Director of Public Affairs at PhRMA focusing on polling and opinion research that supports advocacy communications and strategy. Prior to joining PhRMA, Cynthia worked as a consultant, marketer, and head of polling for a civic technology company where her work supported issue advocacy organizations and policy makers on both sides of the aisle. Cynthia is a proud Los Angeles native and outside of the office she enjoys an early morning HIIT workout and spending time with friends and family.

Cynthia Hicks

Survey confirms too many insured Americans face barriers to reliable health care

April 22, 2026

Americans believe U.S. pharma leadership needs to be protected

February 26, 2026

50-state poll says Americans are concerned that hospital markups hurt patients

January 27, 2026

Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change

March 13, 2025

Reimagining patient access through meaningful policy reform

November 5, 2024

New PES survey: Out-of-pocket costs lead key health care priorities ahead of the November election

October 30, 2024

Americans speak out on health insurance barriers and need for policy change, according to the latest Patient Experience Survey

October 28, 2024

Where voters stand ahead of the election

October 16, 2024

Key voter insights two months from Election Day

September 10, 2024

Don’t put the government between patients and their medicines

August 7, 2024

Voters across all 50 states want state policymakers to focus on health insurance and PBM practices

July 30, 2024

New 50-state poll Americans want to hold health insurers and PBMs accountable for high out-of-pocket costs and other practices

July 9, 2024

The IRA could lead to higher out-of-pocket costs for 3.5 million Medicare patients in 2026

June 25, 2024

ICYMI: What patients care about this election year

June 24, 2024

Key election year voter insights

June 6, 2024

Ongoing federal probes shed light on PBM and insurer practices

May 20, 2024

Critics repeat same, misleading narrative on potential “costs” of new medicines

May 7, 2024

WTAS: The consequences of consolidation and vertical integration

May 6, 2024

Insurance data: PBM reform has no material impact on premiums

April 24, 2024

ICYMI: Voter priorities this election season

April 18, 2024

What recent rhetoric on the cost of diabetes and anti-obesity medicines gets wrong

April 9, 2024

3 Takeaways from POLITICO’s Health Care Summit

April 3, 2024

Voter insights: Four things to know

March 7, 2024

Four years later, Maryland board still hasn’t delivered for patients

February 12, 2024

Setting the Record Straight: Comparing U.S. drug prices to those in foreign countries hurts patients

February 7, 2024

New poll: Americans agree that expanding the TRIPS waiver will harm U.S. global manufacturing and innovation leadership

January 29, 2024

When it comes to the future of innovation, the ball is in policymakers’ court

January 22, 2024

ICYMI: When middlemen get in the way, it’s the patients who lose

December 5, 2023

ICYMI: WSJ — Same Drug, Two Prices: Why the Higher Price Prevails

November 15, 2023

One year to Election Day: Four voter priorities to watch

November 6, 2023

ICYMI: Scott LaGanga and Matt Salo deliver a State of the Industry Report

October 25, 2023

New poll shows strong bipartisan support for PBM reform

October 20, 2023

ICYMI: Government watchdog report finds patients in Medicare Part D paid billions more for medicines than insurers and PBMs

September 28, 2023

Medicare Prescription Payment Plan will benefit patients if implemented correctly

September 21, 2023

New PhRMA ad exposes yet another way PBMs get between patients and their medicines

September 5, 2023

AARP’s latest misleading report

August 11, 2023

New report: Hospitals mark up medicine prices 500%

August 2, 2023

read more

August 2, 2023

Navigating the Patient Experience Survey: Protecting Lifelines to Access and Innovation

July 26, 2023

Three things to know from the latest Patient Experience Survey

July 20, 2023

Key considerations as Congress works towards PAHPA reauthorization

July 12, 2023

ICYMI: PBM exec admits choosing profits over patients

June 2, 2023

Insulin: Key Facts on Access & Affordability

May 10, 2023

4 key facts on medicine prices and spending

May 9, 2023

4 Things to know about PhRMA’s new 50-state poll

May 4, 2023

Americans want state policymakers to lower out-of-pocket costs

May 1, 2023

Three facts about health care spending

April 25, 2023

States can support access to medicine as COVID-19 Public Health Emergency ends

April 5, 2023

Arkansas puts patients first with new share the savings law

April 4, 2023

Key Trends: Patient experience data reveal how insurers and middlemen impose barriers in health care

March 29, 2023

Holding pharmacy benefit managers accountable

February 23, 2023

Stopping pharmacy benefit managers from “gaming the system”

February 22, 2023

Senate hearing to examine bipartisan reforms to rein in middlemen

February 16, 2023

Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines

January 31, 2023

ICYMI: Cancer death rate continues to decline due to treatment advances

January 25, 2023

Novel medicines approved in 2022 offer increased treatment options for patients

January 23, 2023

ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference

January 19, 2023

Study finds hepatitis C cure saved Medicaid $15 billion

January 5, 2023

In their own words: Insured Americans support policy reforms that address access and affordability concerns

December 14, 2022

In their own words: Financial barriers exacerbate access challenges for insured Americans

December 8, 2022

Putting Delaware patients first: Protecting Patient Assistance Programs

November 22, 2022

New data show how insurers and middlemen shift Rx costs onto patients

November 16, 2022

In their own words: Insured Americans struggle to navigate complex coverage

October 26, 2022

Many seniors are paying more for Part D medicines than their insurer

October 18, 2022

New comments outline ways to protect patients from health plans and PBMs who profit from patient assistance

October 7, 2022

Busting 3 Myths About Copay Coupons

October 5, 2022

Mental Illness Awareness Week – A time for reflection

October 3, 2022

A key fact the White House is reluctant to admit

September 27, 2022

A key fact the White House is reluctant to admit

September 27, 2022

Navigating the patient experience: Burdens and barriers standing between patients and their care

September 12, 2022

Making coupons count for patients at the pharmacy counter

August 25, 2022

New survey: Voters seriously concerned about fine print in reconciliation bill

August 12, 2022

Making coupons count for patients with HIV

August 8, 2022

The Senate’s latest price setting proposal will undermine: Our health care system

July 28, 2022

The Senate’s latest price setting proposal will undermine: Patient access to medicines

July 26, 2022

Survey Says: Prescription drug prices are not fueling inflation concerns for Americans

July 22, 2022

Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US

July 14, 2022

Polling continues to show voters reject so-called Medicare “negotiation” once they learn about consequences for patients

July 12, 2022

By the Numbers: Patients lose when the government sets prices

July 8, 2022

Patients win as West Virginia implements first-in-nation share the savings policy

July 8, 2022

3 things voters are concerned about when it comes to their health care coverage

July 7, 2022

Prescription drug prices are not fueling inflation

July 6, 2022

Copay assistance is a lifeline for patients. So why are insurers blocking it?

June 29, 2022

Patients support state action requiring PBMs and insurers to share savings and cap costs for medicines

June 16, 2022

New poll shows voters sounding the alarm on health insurance companies and PBMs

June 6, 2022

PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for patients

May 31, 2022

Report finds PBMs are increasingly restricting patient access to medicines

May 25, 2022

ICYMI: PhRMA CEO Stephen J. Ubl spotlights lessons learned during COVID-19

May 13, 2022

ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

May 9, 2022

Annual projections from NHE compared to actual health care spending

May 5, 2022

Study finds insurance barriers disproportionately burden patients with chronic illness

May 4, 2022

What’s really happening when it comes to prescription drug costs

April 27, 2022

5 public opinion polling trends to watch

April 22, 2022

Analysis: States can help patients save nearly $1,000 annually on their medicines

April 21, 2022

New analysis confirms hospitals markup prices for oncology therapies

April 21, 2022

How standardized plans can improve patients’ access to medicines

April 18, 2022

The patient experience: Uncovering the barriers to care for insured Americans

March 28, 2022

Correcting the record: Putting medicine costs and spending in context

March 24, 2022

Sharing rebates can save Americans with diabetes 500 each year and improve adherence

March 16, 2022

Guest Post: If we truly want to cure complex diseases, politicians should reject price setting

March 14, 2022

Veterans Affairs 101: Three charts show how the VA system differs from Medicare

March 11, 2022

If drug prices are growing below the rate of inflation, why are patients still feeling the sting at the pharmacy?

March 8, 2022

The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved

February 28, 2022

Government price setting leaves behind families counting on new medicines

February 23, 2022

340B 101: Three charts show the program maximizes hospitals’ bottom line with little consideration for patients

February 8, 2022

Medicaid 101: Three charts on access and spending

February 3, 2022

Government price setting won’t stop insurers from shifting costs to patients

February 2, 2022

Research and development continues long after a medicine is initially approved

February 1, 2022

New comments outline ways to counteract cost-shifting insurance trends

January 28, 2022

Patients need to pay less for their medicines. States can help.

January 26, 2022

It’s a new year, but sadly Congress is still pursuing flawed price setting policies

January 25, 2022

CBO reaffirms our innovation ecosystem leads to improved lives, long-term savings

January 21, 2022

New study finds more than half of brand medicine spending goes to the supply chain and others

January 7, 2022

New NHE data show the true picture of health care spending

December 22, 2021

Making medicines more affordable: Preserving safety-net programs like 340B

December 17, 2021

Post-approval research save lives. Why is Congress trying disincentivize it?

December 17, 2021

A price control by any other name would still put patients at risk and threaten innovation

December 9, 2021

Making medicines more affordable: Making insurance work like insurance

December 8, 2021

3 things to know about the importance of post-approval research and development

December 6, 2021

Navigating the patient experience in the time of COVID-19

December 6, 2021

Guest post: Congress should not put future innovation at risk

November 29, 2021

Insurance design barriers can impact patient adherence and can lead to poor health outcomes

November 23, 2021

What is missing in the current drug pricing plan

November 23, 2021

ICYMI: PhRMA CEO speaks at STAT Summit about government price setting

November 19, 2021

Making medicines more affordable: Sharing savings at the pharmacy counter

November 19, 2021

Three things to know about so-called Medicare negotiation polling

November 18, 2021

In the current health care debate, Congress has lost sight of what matters to U.S. voters

November 15, 2021

Making medicines more affordable: Modernizing Medicare

November 11, 2021

Making Medicines More Affordable: Making coupons count

November 5, 2021

What they are saying: Government price setting for medicines is not the answer

November 4, 2021

Four things to know from IQVIAs latest report

October 29, 2021

The patient experience: Insurance design hurdles lead to access issues for too many Americans

October 28, 2021

CMS finds medication adherence saved Medicare up to 46.6B in avoided health care costs between 2013 and 2018

October 19, 2021

The patient experience: Out-of-pocket costs are driving patients affordability and access challenges

October 19, 2021

ICYMI: New study confirms policies like H.R. 3 could significantly reduce drug development

October 18, 2021

New poll shows Americans reject Medicare negotiation once they learn more about the policy

October 15, 2021

To drive up profits, hospitals continue unnecessary medicine mark-ups, burdening patients, employers and health care system

October 14, 2021

What is Kaiser Family Foundation up to?

October 12, 2021

New report shows 3 in 10 Americans that have insurance still face a financial barrier to care

October 7, 2021

Industry leaders discuss the impact of the drug pricing debate

September 23, 2021

Five reasons tying VA prices to Medicare Part D misses the mark

September 22, 2021

America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach

September 15, 2021

Recent polling misrepresents public support for Medicare “negotiation”

August 31, 2021

Myth vs. fact: Polling and Medicare “negotiation”

August 12, 2021

ICYMI: Event spotlights how we can make Medicare work better for patients

August 4, 2021

The future of the rebate rule: Will policymakers stand with patients?

August 2, 2021

Celebrating Medicare’s 56th anniversary

July 30, 2021

Recognizing Hepatitis R&D on World Hepatitis Day

July 28, 2021

Government “negotiation” could have devastating consequences for Medicare enrollees

July 23, 2021

Protecting Medicare from government interference

July 21, 2021

3 factors impacting medication adherence for patients with diabetes

July 20, 2021

Data shows voters strongly support protecting access to their medicines

July 15, 2021

Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

July 2, 2021

Medicare “negotiation” proposals threaten Americans’ access to medicines

June 30, 2021

Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US

June 23, 2021

New reports shed light on key facts about medicines and affordability

June 8, 2021

Out-of-pocket trends in Medicare Part D show rising costs for seniors

May 24, 2021

How strengthening the biosimilar marketplace benefits patients

May 18, 2021

Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs

May 17, 2021

New polling shows Americans are sounding the alarm on the TRIPS IP waiver

May 14, 2021

Four solutions Americans support to make health care more affordable

May 13, 2021

The FDA Office of Minority Health and Health Equity: Working to advance health equity through diversity in research

May 12, 2021

New report demonstrates development of new medicines relies on private sector expertise and investment

May 10, 2021

H.R. 3 threatens access to medicines, future innovation and American jobs

May 4, 2021

New data from insurers show detriments of copay accumulator adjustment programs

April 28, 2021

Data shows that Americans are relying on vaccines to get us through the pandemic

April 22, 2021

West Virginia becomes the first state to lower patient costs by sharing the savings

April 20, 2021

Our three-part approach to build a better health care system

April 13, 2021

Data shows that keeping a strong biopharmaceutical industry is important to Americans

March 30, 2021

Nearly 40% of commercially insured patients face half their annual out-of-pocket expenses from just one health care encounter

March 2, 2021

Top five issues voters want addressed in the administration’s first 100 days

February 18, 2021

Insurers shift medicine costs to patients with severe chronic illnesses

February 1, 2021

Growing trend: Increased vaccine confidence

January 28, 2021

The latest misleading “poll” on drug pricing

January 28, 2021

Election insights: Common ground areas to address Americans’ health care concerns

January 26, 2021

New insulin report highlights how incentives benefit middlemen, harm patients

January 22, 2021

Key facts: The final rebate rule will be a positive change for patients

January 19, 2021

Election insights: Voter priorities in the states

December 17, 2020

Insights from the election: Meeting voters where they are on health care

December 15, 2020

Final rebate rule represents right way to change Medicare

December 1, 2020

Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds

November 19, 2020

Deep dive: The issues that drove the 2020 vote

November 13, 2020

Voters want to address the real drivers of health care costs for patients and the system

November 2, 2020

Three things you should know about recent health care polling

October 23, 2020

Survey found insurance premiums grew faster than inflation in 2020

October 20, 2020

Study finds middlemen excluded nearly 850 medicines from formularies this year

September 17, 2020

Recent administration actions undermine patient assistance programs

September 16, 2020

Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually

August 19, 2020

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas

August 12, 2020

Commercial health plans transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs

August 6, 2020

Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report

August 5, 2020

New data show commercially insured patients face increasingly high cost sharing for brand medicines

July 30, 2020

Payers subject 80% of new RA and MS patients to utilization management restrictions

July 22, 2020

ICYMI: Pharmacy benefit managers increasingly exclude medicines from formularies, restricting patient access

June 1, 2020

New rule makes it harder for patients to lower their out-of-pocket costs

May 20, 2020

ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements

April 20, 2020

PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs

March 3, 2020